MedPath

Clinical study of Huanglian Jiedu Decoction in improving the efficacy of septic cardiomyopathy patients

Phase 1
Conditions
septic cardiomyopathy
Registration Number
ITMCTR2000004108
Lead Sponsor
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for sepsis;
2. Aged between 18 and 70 years;
3. Meet the diagnostic criteria of sepsis cardiomyopathy;
4. Those who meet the standard of TCM syndrome differentiation and classification of heat poison;
5. Volunteer for the test.

Exclusion Criteria

1. Pregnant or lactating women;
2. Mental disorder or unwillingness to cooperate;
3. Patients with primary heart disease;
4. Patients with severe primary diseases and malignant tumors of liver and kidney, blood, endocrine system, etc.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HMGB1;Mitochondrial DNA;Supar;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath